Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Other Accumulated Expenses (2021)

Historic Other Accumulated Expenses for International Stem Cell (ISCO) over the last 1 years, with Q4 2021 value amounting to $300000.0.

  • International Stem Cell's Other Accumulated Expenses changed N/A to $300000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $300000.0, marking a year-over-year change of. This contributed to the annual value of $300000.0 for FY2021, which is N/A changed from last year.
  • According to the latest figures from Q4 2021, International Stem Cell's Other Accumulated Expenses is $300000.0.
  • Over the past 5 years, International Stem Cell's Other Accumulated Expenses peaked at $300000.0 during Q4 2021, and registered a low of $300000.0 during Q4 2021.